Cell Therapeutics Fails To Nix Investor Class Action
A federal judge has refused to dismiss a consolidated class action accusing biopharmaceutical company Cell Therapeutics Inc. and its executives of misleading investors into believing the U.S. Food and Drug Administration...To view the full article, register now.
Already a subscriber? Click here to view full article